Home » Topics » BioWorld Science

BioWorld Science
RSS

Studies explore asprosin as a target for treating binge eating

June 20, 2022

RP Scherer Technologies patents TROP-2-targeting antibody-drug conjugates

June 20, 2022

Anti-glypican-3 antibody-drug conjugates developed at Ardeagen

June 20, 2022

2692372 Ontario, Dunad Therapeutics patent tubulin polymerization inhibitors

June 20, 2022

Chengdu Baiyu Pharmaceutical describes G12C mutant GTPase KRAS inhibitors

June 20, 2022

New MRGPRX2 antagonists identified at Bioardis

June 20, 2022

Novel humanized mouse model of posterior fossa A ependymoma

June 20, 2022

Magmas inhibition as new therapeutic strategy in medulloblastoma

June 20, 2022

CD47 blockade with 225Ac-anti-CD33 radioimmunoconjugate in acute myeloid leukemia

June 20, 2022

Alpha-emitting radioimmunotherapy: using throrium-227 and antibody conjugates

June 20, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...